Literature DB >> 18321461

Effects of acute ischemic mitral regurgitation on three-dimensional mitral leaflet edge geometry.

Wolfgang Bothe1, Tom C Nguyen, Daniel B Ennis, Akinobu Itoh, Carl Johan Carlhäll, David T Lai, Neil B Ingels, D Craig Miller.   

Abstract

BACKGROUND: Improved quantitative understanding of in vivo leaflet geometry in ischemic mitral regurgitation (IMR) is needed to improve reparative techniques, yet few data are available due to current imaging limitations. Using marker technology we tested the hypotheses that IMR (1) occurs chiefly during early systole; (2) affects primarily the valve region contiguous with the myocardial ischemic insult; and (3) results in systolic leaflet edge restriction.
METHODS: Eleven sheep had radiopaque markers sutured as five opposing pairs along the anterior (A(1)-E(1)) and posterior (A(2)-E(2)) mitral leaflet free edges from the anterior commissure (A(1)-A(2)) to the posterior commissure (E(1)-E(2)). Immediately postoperatively, biplane videofluoroscopy was used to obtain 4D marker coordinates before and during acute proximal left circumflex artery occlusion. Regional mitral orifice area (MOA) was calculated in the anterior (Ant-MOA), middle (Mid-MOA), and posterior (Post-MOA) mitral orifice segments during early systole (EarlyS), mid systole (MidS), and end systole (EndS). MOA was normalized to zero (minimum orifice opening) at baseline EndS. Tenting height was the distance of the midpoint of paired markers to the mitral annular plane at EndS.
RESULTS: Acute ischemia increased echocardiographic MR grade (0.5+/-0.3 vs 2.3+/-0.7, p<0.01) and MOA in all regions at EarlyS, MidS, and EndS: Ant-MOA (7+/-10 vs 22+/-19 mm(2), 1+/-2 vs 18+/-16 mm(2), 0 vs 17+/-15 mm(2)); Mid-MOA (9+/-13 vs 25+/-17 mm(2), 3+/-6 vs 21+/-19 mm(2), 0 vs 25+/-17 mm(2)); and Post-MOA (8+/-10 vs 25+/-16, 2+/-4 vs 22+/-13 mm(2), 0 vs 23+/-13 mm(2)), all p<0.05. There was no change in MOA throughout systole (EarlyS vs MidS vs EndS) during baseline conditions or ischemia. Tenting height increased with ischemia near the central and the anterior commissure leaflet edges (B(1)-B(2): 7.1+/-1.8mm vs 7.9+/-1.7 mm, C(1)-C(2): 6.9+/-1.3mm vs 8.0+/-1.5mm, both p<0.05).
CONCLUSIONS: MOA during ischemia was larger throughout systole, indicating that acute IMR in this setting is a holosystolic phenomenon. Despite discrete postero-lateral myocardial ischemia, Post-MOA was not disproportionately larger. Acute ovine IMR was associated with leaflet restriction near the central and the anterior commissure leaflet edges. This entire constellation of annular, valvular, and subvalvular ischemic alterations should be considered in the approach to mitral repair for IMR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18321461      PMCID: PMC2277480          DOI: 10.1016/j.ejcts.2007.10.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  18 in total

1.  Annuloplasty ring selection for chronic ischemic mitral regurgitation: lessons from the ovine model.

Authors:  Joseph H Gorman; Robert C Gorman; Benjamin M Jackson; Yoshiharu Enomoto; Martin G St John-Sutton; L Henry Edmunds
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330

2.  Computer-generated three-dimensional animation of the mitral valve.

Authors:  Joseph H Dayan; Aaron Oliker; Ram Sharony; F Gregory Baumann; Aubrey Galloway; Stephen B Colvin; D Craig Miller; Eugene A Grossi
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

3.  Automatic tracking and digitization of multiple radiopaque myocardial markers.

Authors:  M A Niczyporuk; D C Miller
Journal:  Comput Biomed Res       Date:  1991-04

4.  The effects of mitral annuloplasty rings on mitral valve complex 3-D geometry during acute left ventricular ischemia.

Authors:  David T Lai; Tomasz A Timek; Frederick A Tibayan; G Randall Green; George T Daughters; David Liang; Neil B Ingels; D Craig Miller
Journal:  Eur J Cardiothorac Surg       Date:  2002-11       Impact factor: 4.191

5.  Tenting volume: three-dimensional assessment of geometric perturbations in functional mitral regurgitation and implications for surgical repair.

Authors:  Frederick A Tibayan; Ariane Wilson; David T M Lai; Tomasz A Timek; Paul Dagum; Filiberto Rodriguez; Mary K Zasio; David Liang; George T Daughters; Neil B Ingels; D Craig Miller
Journal:  J Heart Valve Dis       Date:  2007-01

6.  Geometric distortions of the mitral valvular-ventricular complex in chronic ischemic mitral regurgitation.

Authors:  Frederick A Tibayan; Filiberto Rodriguez; Mary K Zasio; Lynn Bailey; David Liang; George T Daughters; Frank Langer; Neil B Ingels; D Craig Miller
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

7.  Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement.

Authors:  E Messas; J L Guerrero; M D Handschumacher; C M Chow; S Sullivan; E Schwammenthal; R A Levine
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

8.  Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction.

Authors:  Toshiro Kumanohoso; Yutaka Otsuji; Shiro Yoshifuku; Keiko Matsukida; Chihaya Koriyama; Akira Kisanuki; Shinichi Minagoe; Robert A Levine; Chuwa Tei
Journal:  J Thorac Cardiovasc Surg       Date:  2003-01       Impact factor: 5.209

9.  Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern.

Authors:  Eustachio Agricola; Michele Oppizzi; Francesco Maisano; Michele De Bonis; Arend F L Schinkel; Lucia Torracca; Alberto Margonato; Giulio Melisurgo; Ottavio Alfieri
Journal:  Eur J Echocardiogr       Date:  2004-10

10.  Mechanistic insights into posterior mitral leaflet inter-scallop malcoaptation during acute ischemic mitral regurgitation.

Authors:  David T Lai; Frederick A Tibayan; Truls Myrmel; Tomasz A Timek; Paul Dagum; George T Daughters; David Liang; Neil B Ingels; D Craig Miller
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

View more
  6 in total

1.  The unique mechanism of functional mitral regurgitation in acute myocardial infarction: a prospective dynamic 4D quantitative echocardiographic study.

Authors:  Toshiyuki Kimura; Véronique L Roger; Nozomi Watanabe; Sergio Barros-Gomes; Yan Topilsky; Shun Nishino; Yoshisato Shibata; Maurice Enriquez-Sarano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-04-01       Impact factor: 6.875

Review 2.  [Modern mitral valve surgery].

Authors:  W Bothe; F Beyersdorf
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

3.  Mitral annulus segmentation from four-dimensional ultrasound using a valve state predictor and constrained optical flow.

Authors:  Robert J Schneider; Douglas P Perrin; Nikolay V Vasilyev; Gerald R Marx; Pedro J del Nido; Robert D Howe
Journal:  Med Image Anal       Date:  2011-12-04       Impact factor: 8.545

4.  Mitral annulus segmentation from 3D ultrasound using graph cuts.

Authors:  Robert J Schneider; Douglas P Perrin; Nikolay V Vasilyev; Gerald R Marx; Pedro J del Nido; Robert D Howe
Journal:  IEEE Trans Med Imaging       Date:  2010-06-17       Impact factor: 10.048

5.  Effects of different annuloplasty ring types on mitral leaflet tenting area during acute myocardial ischemia.

Authors:  Wolfgang Bothe; John-Peder Escobar Kvitting; Elizabeth H Stephens; Julia C Swanson; David H Liang; Neil B Ingels; D Craig Miller
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02       Impact factor: 5.209

6.  Regional mitral leaflet opening during acute ischemic mitral regurgitation.

Authors:  Wolfgang Bothe; Daniel B Ennis; Carl Johan Carlhäll; Tom C Nguyen; Tomasz A Timek; David T Lai; Akinobu Itoh; Neil B Ingels; D Craig Miller
Journal:  J Heart Valve Dis       Date:  2009-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.